Commvault
System Engineer
Neusoft Dec 2005 - Mar 2013
Senior Consultant
Education:
Beijing University of Posts and Telecommunications 2009 - 2012
Master of Business Administration, Masters
North China University of Technology 1996 - 1999
Skills:
Storage Virtualization Storage Area Networks San Vmware Nas Cloud Computing Data Center Disaster Recovery Netapp High Availability Storage Virtualization Enterprise Storage Unix Vmware Esx
Mirati Therapeutics Sep 2016 - May 2018
Associate Director, Product Development and Cmc
Ansun Biopharma, Inc. Sep 2016 - May 2018
Senior Director of Product Development
Nexbio Feb 2007 - Sep 2016
Assistant Director
Education:
Peking University 2016 - 2020
Bachelors, Bachelor of Science
University of California, Los Angeles 1998 - 2004
Doctorates, Doctor of Philosophy, Chemistry
Peking University 1992 - 1997
Bachelors, Bachelor of Science, Chemistry
Skills:
Biotechnology Peptides Formulation Product Development Inhalation
Weatherford
Deputy General Manager
Weatherford Oct 2016 - Jan 2017
General Manager Assistant
Weatherford Feb 2009 - Dec 2015
Senior Service Engineer, Surface Logging Coordinator
International Logging Overseas Aug 2005 - Jan 2009
Service Engineer
Huabei Mud Logging Company Petro China Apr 1994 - Jul 2005
Technician Support Supervisor, Mud Logging Specialist
A method of reducing or treating parainfluenza or influenza virus infection in an immunocompromised patient by administering to the respiratory tract of the patient a composition comprising a therapeutically effective amount of protein having sialidase activity.
Microparticle Formulations For Delivery To The Lower And Central Respiratory Tract And Methods Of Manufacture
Microparticle formulations of a sialidase fusion protein are produced by contacting an aqueous solution of a protein or other active agent with an organic solvent, a counterion and a scavenging agent, and chilling the solution. The microparticles are useful for preparing stable, uniform pharmaceuticals of predetermined defined dimensions.
Methods, Compounds And Compositions For Treatment Of Influenza And Parainfluenza Patients
A method of reducing or treating parainfluenza or influenza virus infection in an immunocompromised patient by administering to the respiratory tract of the patient a composition comprising a therapeutically effective amount of protein having sialidase activity.
Microparticle Formulations For Delivery To The Lower And Central Respiratory Tract And Methods Of Manufacture
Microparticle formulations of a sialidase fusion protein are produced by contacting an aqueous solution of a protein or other active agent with an organic solvent, a counterion and a scavenging agent, and chilling the solution. The microparticles are useful for preparing stable, uniform pharmaceuticals of predetermined defined dimensions.
Microparticle Formulations For Delivery To The Lower And Central Respiratory Tract And Methods Of Manufacture
Microparticle formulations of a sialidase fusion protein are produced by contacting an aqueous solution of a protein or other active agent with an organic solvent, a counterion and a scavenging agent, and chilling the solution. The microparticles are useful for preparing stable, uniform pharmaceuticals of predetermined defined dimensions.
Methods, Compounds And Compositions For Treatment Of Influenza And Parainfluenza Patients
A method of reducing or treating parainfluenza or influenza virus infection in an immunocompromised patient by administering to the respiratory tract of the patient a composition comprising a therapeutically effective amount of protein having sialidase activity.
Microparticle Formulations For Delivery To The Lower And Central Respiratory Tract And Methods Of Manufacture
Microparticle formulations of a sialidase fusion protein are produced by contacting an aqueous solution of a protein or other active agent with an organic solvent, a counterion and a scavenging agent, and chilling the solution. The microparticles are useful for preparing stable, uniform pharmaceuticals of predetermined defined dimensions.
Methods, Compounds And Compositions For Treatment Of Influenza And Parainfluenza Patients
A method of reducing or treating parainfluenza or influenza virus infection in an immunocompromised patient by administering to the respiratory tract of the patient a composition comprising a therapeutically effective amount of protein having sialidase activity.